B12 in blood: what supplement studies found
How B12 and related blood markers changed with different regimens and at borderline baseline levels.
Key points
- In vegans and vegetarians with low baseline B12, average vitamin levels rose with both studied regimens. From day 30 to day 90, levels were higher with 2,000 µg once weekly than with 50 µg daily. [1] See the evidence 1
- In the same study, other B12 status markers improved with both regimens, with no convincing difference between them. Blood tests show marker changes and do not by themselves describe how a person feels. [1] See the evidence 1 2 3
- In adults with borderline B12, one month of 1,000 µg daily reduced methylmalonic acid compared with placebo. Three months after stopping, the difference was no longer detected. [2] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
B12 levels and related blood markers were studied in different groups. Regimens and laboratory results should be interpreted in the context of the studies.
Key points
Why these conclusions
How blood markers changed
Vegans and vegetarians with B12 below 220 pmol/L took cyanocobalamin tablets labelled as sublingual: 50 µg daily or 2,000 µg once weekly for 90 days. Mean B12 rose above 240 pmol/L in both groups; from day 30 to day 90 the level was higher with the weekly regimen. Confidence is low, 2 out of 4. [1]
In both groups holotranscobalamin—B12 bound to a carrier protein—increased, and methylmalonic acid and homocysteine decreased. No convincing differences between the regimens were found for these three markers; this was one study, not three separate studies. [1]
In another study of adults with B12 of 125–200 pmol/L, 1,000 µg B12 daily was compared with placebo for four weeks. At one month methylmalonic acid was 0.23 versus 0.37 µmol/L; three months after stopping, the difference was no longer detected. Confidence is moderate, 3 out of 4. [2]
Mean B12 rose above 240 pmol/L in both groups. From day 30 to day 90, it was higher with 2,000 µg once weekly than with 50 µg daily (between-group comparison at those times: p<0.01).
| Parameter | Data |
|---|---|
| Result | Mean B12 rose above 240 pmol/L in both groups. From day 30 to day 90, it was higher with 2,000 µg once weekly than with 50 µg daily (between-group comparison at those times: p<0.01). |
| Participants | 40 vegans and vegetarians with B12 <220 pmol/L; 36 completed the study, 18 per group |
| Form | Cyanocobalamin tablets labelled as sublingual |
| Dose | 50 µg daily (350 µg per week) |
| Dose basis | 50 µg daily (350 µg per week) |
| Comparator | 2,000 µg cyanocobalamin once weekly and placebo on the other 6 days |
| Duration | 90 days |
| Confidence | 2/4: One small study with two active regimens and no group receiving no B12. Laboratory tests were completed by 36 of 40 participants. A blood marker change alone does not show a change in how a person feels. |
| Evidence base | 1 study |
| Sources | [1] |
Holotranscobalamin—B12 bound to a carrier protein—increased in both groups (change over time: p<0.0001). No convincing difference between regimens was found.
| Parameter | Data |
|---|---|
| Result | Holotranscobalamin—B12 bound to a carrier protein—increased in both groups (change over time: p<0.0001). No convincing difference between regimens was found. |
| Participants | 40 vegans and vegetarians with B12 <220 pmol/L; 36 completed the study, 18 per group |
| Form | Cyanocobalamin tablets labelled as sublingual |
| Dose | 50 µg daily (350 µg per week) |
| Dose basis | 50 µg daily (350 µg per week) |
| Comparator | 2,000 µg cyanocobalamin once weekly and placebo on the other 6 days |
| Duration | 90 days |
| Confidence | 2/4: One small study with two active regimens and no group receiving no B12. Laboratory tests were completed by 36 of 40 participants. A blood marker change alone does not show a change in how a person feels. |
| Evidence base | 1 study |
| Sources | [1] |
Methylmalonic acid, a marker that can rise with B12 deficiency, fell in both groups (change over time: p<0.0001). No convincing difference between regimens was found.
| Parameter | Data |
|---|---|
| Result | Methylmalonic acid, a marker that can rise with B12 deficiency, fell in both groups (change over time: p<0.0001). No convincing difference between regimens was found. |
| Participants | 40 vegans and vegetarians with B12 <220 pmol/L; 36 completed the study, 18 per group |
| Form | Cyanocobalamin tablets labelled as sublingual |
| Dose | 50 µg daily (350 µg per week) |
| Dose basis | 50 µg daily (350 µg per week) |
| Comparator | 2,000 µg cyanocobalamin once weekly and placebo on the other 6 days |
| Duration | 90 days |
| Confidence | 2/4: One small study with two active regimens and no group receiving no B12. Laboratory tests were completed by 36 of 40 participants. A blood marker change alone does not show a change in how a person feels. |
| Evidence base | 1 study |
| Sources | [1] |
Blood homocysteine fell in both groups (change over time: p<0.0001). No convincing difference between regimens was found. This is a blood test result; well-being was not assessed by it.
| Parameter | Data |
|---|---|
| Result | Blood homocysteine fell in both groups (change over time: p<0.0001). No convincing difference between regimens was found. This is a blood test result; well-being was not assessed by it. |
| Participants | 40 vegans and vegetarians with B12 <220 pmol/L; 36 completed the study, 18 per group |
| Form | Cyanocobalamin tablets labelled as sublingual |
| Dose | 50 µg daily (350 µg per week) |
| Dose basis | 50 µg daily (350 µg per week) |
| Comparator | 2,000 µg cyanocobalamin once weekly and placebo on the other 6 days |
| Duration | 90 days |
| Confidence | 2/4: One small study with two active regimens and no group receiving no B12. Laboratory tests were completed by 36 of 40 participants. A blood marker change alone does not show a change in how a person feels. |
| Evidence base | 1 study |
| Sources | [1] |
At one month methylmalonic acid was 0.23 µmol/L with B12 and 0.37 µmol/L with placebo. Baseline-adjusted difference: −0.13 µmol/L (95% confidence interval −0.19 to −0.06). Three months after stopping, the difference was no longer detected.
| Parameter | Data |
|---|---|
| Result | At one month methylmalonic acid was 0.23 µmol/L with B12 and 0.37 µmol/L with placebo. Baseline-adjusted difference: −0.13 µmol/L (95% confidence interval −0.19 to −0.06). Three months after stopping, the difference was no longer detected. |
| Participants | 50 adults with B12 of 125–200 pmol/L at screening; participants aged 18–91 years |
| Form | B12, oral tablets |
| Dose | 1,000 µg per day |
| Dose basis | 1,000 µg per day |
| Comparator | Placebo tablets |
| Duration | 4 weeks of use; repeat test 3 months after stopping |
| Confidence | 3/4: The result concerns a specific blood test, not symptom relief. The study included 50 people; the one-month test was available for 45. A reduction in the marker was confirmed, but sustained effect after stopping was not shown. |
| Evidence base | 1 study |
| Sources | [2] |
More details
How to interpret test results
The dose comparison applies to vegans and vegetarians with low baseline B12 and two specific regimens; the study had no group without B12. Blood markers alone do not show how well-being changed. [1]
Sources
- Effect of two different sublingual dosages of vitamin B(12) on cobalamin nutritional status in vegans and vegetarians with a marginal deficiency: A randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/29499976/
- Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial. https://doi.org/10.1186/1471-2296-12-2
Methodology: Subpages evidence-led supplement pipeline v1